Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

ABSTRACT: Patients with COPD using long-term oxygen therapy (LTOT) over 15 h per day have improved outcomes. As inhalation of dry cold gas is detrimental to mucociliary clearance, humidified nasal high flow (NHF) oxygen may reduce frequency of exacerbations, while improving lung function and quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraser, John F, Spooner, Amy J, Dunster, Kimble R, Anstey, Chris M, Corley, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975837/
https://www.ncbi.nlm.nih.gov/pubmed/27015801
http://dx.doi.org/10.1136/thoraxjnl-2015-207962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975837/
https://www.ncbi.nlm.nih.gov/pubmed/27015801
http://dx.doi.org/10.1136/thoraxjnl-2015-207962

Ejemplares similares